Theravance Biopharma (TBPH) Tops Q2 EPS by 44c, Revenues Beat

Go back to Theravance Biopharma (TBPH) Tops Q2 EPS by 44c, Revenues Beat
(NASDAQ: TBPH) Delayed: 16.96 +0.04 (0.24%)
Previous Close $16.92    52 Week High $38.92 
Open $16.91    52 Week Low $12.87 
Day High $16.97    P/E N/A 
Day Low $16.91    EPS $0.00 
Volume 112,208